Cantel Medical Corp. (CMD)
(Delayed Data from NYSE)
$68.92 USD
+0.38 (0.55%)
Updated May 3, 2019 04:02 PM ET
After-Market: $68.94 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$68.92 USD
+0.38 (0.55%)
Updated May 3, 2019 04:02 PM ET
After-Market: $68.94 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
When Does Market Timing Actually Work? - October 03, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Cantel Medical Enters Oversold Territory
by Zacks Equity Research
Cantel Medical Corp. (CMD) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Cantel (CMD) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Cantel (CMD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Cantel Medical (CMD) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Cantel (CMD) delivered earnings and revenue surprises of 3.28% and 0.37%, respectively, for the quarter ended July 2019. Do the numbers hold clues to what lies ahead for the stock?
The Truth About Market Timing - September 13, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Yes, You Can Time the Market. Find out How - August 26, 2019
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Simple Market Timing Strategies That Work - August 05, 2019
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
New Strong Sell Stocks for June 14th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
New Strong Sell Stocks for June 12th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Company News For Jun 5, 2019
by Zacks Equity Research
Companies In The News Are: TIF,VTR,NAV,CMD
Cantel Medical (CMD) Meets Q3 Earnings Estimates
by Zacks Equity Research
Cantel (CMD) delivered earnings and revenue surprises of 0.00% and 1.15%, respectively, for the quarter ended April 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Cantel Medical (CMD) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Cantel (CMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cantel Medical (CMD) Q1 Earnings Surpass Estimates
by Zacks Equity Research
Cantel (CMD) delivered earnings and revenue surprises of 3.33% and -0.93%, respectively, for the quarter ended October 2018. Do the numbers hold clues to what lies ahead for the stock?
Cantel Medical (CMD) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Cantel (CMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cantel Medical (CMD) Meets Q4 Earnings Estimates
by Zacks Equity Research
Cantel (CMD) delivered earnings and revenue surprises of 0.00% and 0.77%, respectively, for the quarter ended July 2018. Do the numbers hold clues to what lies ahead for the stock?
Cantel Medical (CMD) Q4 Earnings Preview: What's Shaping Up?
by Zacks Equity Research
Cantel (CMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cantel Medical Corp. (CMD) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Cantel Medical Corp. (CMD) Sees Hammer Chart Pattern: Time to Buy?
Should Vanguard S&P Small-Cap 600 Growth ETF (VIOG) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for VIOG
What Falling Estimates & Price Mean for Natus Medical (BABY)
by Zacks Equity Research
It seems to be a wise decision for investors to drop Natus Medical (BABY) stock considering its negative estimate revision, price depreciation as well as unfavorable Zacks rank.